Thyroid Cancer
Thyroidectomy without radioiodine noninferior for patients with low-risk thyroid cancer
A follow-up strategy without radioiodine appeared noninferior to an ablation strategy with radioiodine among patients with low-risk thyroid cancer undergoing thyroidectomy, according to study results in The New England Journal of Medicine.
AI platform predicts thyroid cancer, pathologic stage, BRAF status using ultrasound images
An artificial intelligence platform predicted thyroid cancer with high accuracy based on analysis of routine ultrasound images, according to study results presented at Multidisciplinary Head and Neck Cancers Symposium.
For researcher and thyroid cancer expert, career change has been ‘positive and energizing’
Marcia S. Brose, MD, PhD, said she is not the kind of person who typically seeks out change.
Most indeterminate thyroid nodules diagnosed with repeat fine-needle aspiration
Repeat fine-needle aspiration can diagnose more than half of thyroid nodules initially classified as indeterminate, but diagnosis rates are less than 50% with nodules smaller than 0.5 cm or larger than 1 cm, according to study data.
Risk stratification, molecular testing among recent advances in thyroid cancer treatment
During the past 2 decades, Endocrine Today has reported on the latest developments in treating thyroid cancer. For its 20th year, the publication is taking a look back.
Age cutoff of 14 years may be more suitable than 18 years for pediatric thyroid cancer
A cutoff of age 15 years for pediatric differentiated thyroid cancer care may be more appropriate than the American Thyroid Association’s cutoff of 18 years due to risk factors related to survival rates, according to study data.
Top 2021 thyroid news: Food and thyroid function, molecular testing for cancer and more
The Healio and Endocrine Today editors have compiled the most popular thyroid news stories from 2021.
Novel risk classifier could facilitate earlier prediction of thyroid cancer recurrence
A risk model based on combinatorial messenger RNA and microRNA expression has potential clinical utility as a prognostic indicator of thyroid cancer recurrence, according to researchers.
Thyroid cancer specialist joins Sidney Kimmel Cancer Center at Jefferson
Sidney Kimmel Cancer Center — Jefferson Health appointed Marcia Brose, MD, PhD, vice chair of medical oncology and regional chief of cancer services at Jefferson Torresdale Hospital.
Increased cancer risk observed decades after radioactive iodine treatment
Young adults who received radioactive iodine therapy for differentiated thyroid cancer were at 92% increased risk for leukemia and 23% increased risk for any solid malignancies vs. those who did not receive radioactive iodine therapy.